Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation
Sign Up to like & getrecommendations! Published in 2020 at "Health and Quality of Life Outcomes"
DOI: 10.1186/s12955-020-01349-5
Abstract: Background Hepatitis B immunoglobulin (HBIG) therapy is available in intravenous (IV) or intra-muscular (IM) formulations. Recently, a subcutaneous (SC) formulation was introduced. This study evaluated changes in quality of life when liver transplant (LT) recipients… read more here.
Keywords: quality life; life; life liver; hepatitis immunoglobulin ... See more keywords